Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Aug 8, 2019, before the open
10-Q filed Aug 8, 2019, 39 days after period end · 0001564590-19-030747
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | — | $1.33M | — | — |
| Net Income | -$5.68M | -$5.99M | -$5.52M | -$4.39M |
| EPS Diluted |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$0.14 |
| -$0.22 |
| -$0.21 |
| -$6.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.